Cargando…
The Impact of Body Mass Index Upon the Efficacy of Adalimumab in Hidradenitis Suppurativa
Elevated BMI in Hidradenitis Suppurativa is associated with decreased response to Adalimumab therapy. BMI is proposed to segregate distinct disease subtypes. It remains unresolved whether a threshold BMI exists above which increased dosages may provide clinical benefit. Individual patient data from...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257943/ https://www.ncbi.nlm.nih.gov/pubmed/34239882 http://dx.doi.org/10.3389/fmed.2021.603281 |